Viewing Study NCT00868192


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2026-01-01 @ 11:44 PM
Study NCT ID: NCT00868192
Status: COMPLETED
Last Update Posted: 2014-10-20
First Post: 2009-03-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Sponsor: Washington University School of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 08-0508 / 201102272
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View